Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 429, Issue 1-3, Pages 101-113Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(01)01310-3
Keywords
complex regional pain syndrome; neurogenic inflammation; pain; oedema; temperature; neuropeptide; cytokine; eicosanoid
Categories
Ask authors/readers for more resources
This review focuses on some clinical aspects of the complex regional pain syndrome, such as oedema, local temperature changes and chronic pain, as a result of supposed neurogenic inflammation. Involvement of the immune system could imply the subsequent release of neuropeptides, pro-inflammatory cytokines and eicosanoids, which in turn leads to a complex cross-talk of primary and secondary generated mediators of inflammation. The development and application of drugs that act through selective receptor antagonism or enzymatic synthesis inhibition to prevent further stimulation of this cascade that could inevitably lead to chronicity of this disease are extensively discussed. (C) 2001 Elsevier Science BN. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available